4 completed, 2 terminated, 1 withdrawn. 3 Not applicable, 2 Phase 3, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Withdrawn 1 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 4 | 1 | Completed 1 |
Follow CR-CSSS Champlain-Charles-Le Moyne: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population With Obesity Piperacillin-tazobactam administered in a prolonged infusion, Piperacillin-tazobactam administered in a standard infusion - Infections, Obesity and Obesity-related Medical Conditions | Phase 4 | Completed | CR-CSSS Champlain-Charles-Le Moyne | 45 | 2025-02-26 | 2026-03-17 |
| Audit and Feedback Interventions With Primary Care Nursing Teams Audit and feedback - Nurse's Role | Not applicable | Withdrawn | CR-CSSS Champlain-Charles-Le Moyne | 2021-09-02 | 2021-01-27 | |
| Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospitalized Adult Population Vancomycin dose adjustment using the Bayesian method, Vancomycin dose adjustment using the trough level method - Vancomycin, Adult | Not applicable | Completed | CR-CSSS Champlain-Charles-Le Moyne | 45 | 2021-03-01 | 2021-09-10 |
| Feasibility of Olanzapine at REduced doSe in hIGHly Emetogenic chemoTherapy Zyprexa® (OLANZapine 5MG), Emend® (Aprepitant) - Chemotherapy-induced Nausea and Vomiting | Phase 3 | Completed | CR-CSSS Champlain-Charles-Le Moyne | 30 | 2019-04-29 | 2020-08-19 |
| HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer HDR brachytherapy as monotherapy - Prostate Cancer | Not applicable | Completed | CR-CSSS Champlain-Charles-Le Moyne | 199 | 2015-06-22 | 2022-03-17 |
| Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer Ciprofloxacin, Cefazolin - Prostate Cancer | Phase 3 | Terminated | CR-CSSS Champlain-Charles-Le Moyne | 158 | 2015-02-10 | 2025-02-12 |
| Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer aflibercept + FOLFIRI - Metastatic Colorectal Cancer | Phase 2 | Terminated | CR-CSSS Champlain-Charles-Le Moyne | 14 | 2014-01-01 | 2016-11-16 |
Prostatic Neoplasms (2) · Colorectal Neoplasms (1) · Infections (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Obesity (1) · Vomiting (1)
Aprepitant (1) · Cefazolin (1) · Ciprofloxacin (1) · IFL protocol (1) · Olanzapine (1) · aflibercept (1)
Canada (6)
Benoit Samson, MD (1) · Catherine Prady, Md (1) · Marjory Jolicoeur, MD (1) · Marjory Jolicoeur, MD,MSc (1)